Paola Curci
Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari(IT)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Chronic Lymphocytic Leukemia Research, Peptidase Inhibition and Analysis, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → Spontaneous remission of “methotrexate-associated lymphoproliferative disorders” after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature(2008)133 cited
- → Myeloma cells suppress osteoblasts through sclerostin secretion(2011)128 cited
- → Sclerostin is overexpressed by plasma cells from multiple myeloma patients(2011)85 cited
- → High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma(2022)82 cited
- → Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma(2002)80 cited
- → Regression analysis for energy demand projection: An application to TIMES-Basilicata and TIMES-Italy energy models(2020)67 cited
- → High Ki67 Index and Bulky Disease Remain Significant Adverse Prognostic Factors in Patients with Diffuse Large B Cell Lymphoma before and after the Introduction of Rituximab(2011)65 cited
- → LIGHT/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease(2014)58 cited
- → Daratumumab in light chain deposition disease: rapid and profound hematologic response preserves kidney function(2020)47 cited
- → Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross‐talk in the bone marrow of multiple myeloma patients(2012)35 cited